The role of PI3'‐lipid signalling in melanoma initiation, progression and maintenance.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 1, p. 43, doi. 10.1111/exd.14489
- By:
- Publication type:
- Article
Works matching IS 09066705 AND DT 2022 AND VI 31 AND IP 1
Results: 11
1
2
Location, location, location: Melanoma cells "living at the edge".
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 1, p. 82, doi. 10.1111/exd.14423
- By:
- Publication type:
- Article
3
Re‐thinking therapeutic development for CNS metastatic disease.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 1, p. 74, doi. 10.1111/exd.14413
- By:
- Publication type:
- Article
4
Issue Information.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 1, p. 1, doi. 10.1111/exd.14369
- Publication type:
- Article
5
Ultra‐high‐frequency ultrasound and machine learning approaches for the differential diagnosis of melanocytic lesions.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 1, p. 94, doi. 10.1111/exd.14330
- By:
- Publication type:
- Article
6
Genetic drivers of non‐cutaneous melanomas: Challenges and opportunities in a heterogeneous landscape.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 1, p. 13, doi. 10.1111/exd.14287
- By:
- Publication type:
- Article
7
Melanoma brain metastases: Biological basis and novel therapeutic strategies.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 1, p. 31, doi. 10.1111/exd.14286
- By:
- Publication type:
- Article
8
Long non‐coding RNA LINC00665 promotes melanoma cell growth and migration via regulating the miR‐224‐5p/VMA21 axis.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 1, p. 64, doi. 10.1111/exd.14246
- By:
- Publication type:
- Article
9
BRN2 and MITF together impact AXL expression in melanoma.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 1, p. 89, doi. 10.1111/exd.14225
- By:
- Publication type:
- Article
10
Biomarkers in melanoma and non‐melanoma skin cancer prevention and risk stratification.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 1, p. 4, doi. 10.1111/exd.14114
- By:
- Publication type:
- Article
11
Sorafenib induces pigmentation via the regulation of β‐catenin signalling pathway in melanoma cells.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 1, p. 57, doi. 10.1111/exd.14112
- By:
- Publication type:
- Article